Kiromic Biopharma, Inc. Shareholder Notificaiton: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Kiromic Biopharma, Inc. (KRBP) SAN DIEGO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or...

Kiromic BioPharma, Inc. Investors: Class action lawsuit filed on behalf of investors; Deadline October 4, 2022; the Portnoy Law Firm Investors with Losses of $100,000 can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kiromic...

Kiroma BioPharma, Inc. Investors: Company Investigated by the Portnoy Law Firm ​LOS ANGELES, July 29, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kiroma BioPharma, Inc. ("Kiroma" or the "Company") (NASDAQ: KRBP) investors that the firm has initiated an investigation...